OECD Home › Health › By Country › Italy
Italy has significantly improved the quality of health care in recent decades but needs to tackle the wide disparities that remain between regions, according to a new OECD report.
This report reviews the quality of health care in Italy, seeks to highlight best practices, and provides a series of targeted assessments and recommendations for further improvements to quality of care. Italy’s indicators of health system outcomes, quality and efficiency are uniformly impressive. Life expectancy is the fifth highest in the OECD. Avoidable admission rates are amongst the very best in the OECD, and case-fatality
English, PDF, 261kb
Italy's indicators of health status and quality of care remain among the best in the EU. Italy spent 9.2% of its GDP on health in 2012, slightly more than the EU average of 8.7%.
Specific country notes have been prepared using data from the database OECD Health Statistics 2014, June 2014 version. The notes are available in PDF format.
English, PDF, 346kb
Health spending per capita in real terms fell by 2% in Italy in 2011, and is estimated to have fallen by a further 0.4% in 2012. Spending per capita also fell in 10 other European countries between 2009 and 2011, following the recession and the need for fiscal consolidation, according to a new OECD report.
The global economic crisis has had a profound impact on people’s well-being, reaching far beyond the loss of jobs and income, and affecting citizens’ satisfaction with their lives and their trust in governments, according to a new OECD report.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.
English, , 82kb
This working paper provides a preliminary overview of the main hospital administrative data sets potentially available in Australia, Belgium, Canada, Denmark, Finland, France, United Kingdom, Italy, Sweden and the United States.
Regulatory Developments in Xenotransplantation in Italy.